Robert Brady, LAW JD ’72, received a Distinguished Service and Leadership Award on Dec 6, presented by the Food and Drug Law Institute. Brady, a partner in the Washington, D.C. law firm of Hogan Lovells, focuses his practice on pharmaceutical and biotechnology product law.
Brady has been named one of the leading Food and Drug lawyers in Washington, DC by Legal Times (September 2005); included in The Best Lawyers in America (2010); included in the 2011 edition of Washington DC’s Best Lawyers; and received a “first tier” ranking from Chambers USA (2009; 2010; 2011).
He counsels clients on all aspects of product development and clinical investigation; product approvals; and product promotion and post-approval requirements on a wide array of civil and criminal enforcement issues. He regularly counsels clients and conducts assessments of good clinical practices, good manufacturing practices and safety reporting, continuing medical education, research grants, scientific exchange and dissemination of medical information, and post-approval advertising and promotion conduct. He also counsels companies on all aspects of marketing and promoting over-the-counter drug products, as well as cosmetics.
From 1981 to 1983, he served as the executive assistant to the Commissioner of the FDA. His government career with the FDA’s Office of Chief Counsel began in 1975, when he served in several positions including associate chief counsel for biologics, associate chief counsel for foods, and associate chief counsel for enforcement.